Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Collegium Pharmaceutical
COLL
$913M
| $2.2M | ﹤0.01% |
73,703
-6,051
| -8% | -$185K |
|
2527
Newell Brands
NWL
$2.62B
| $2.2M | ﹤0.01% |
354,653
-161,816
| -31% | -$1.3M |
|
2528
CALL
Telephone and Data Systems
TDS
$4.03B
| $2.19M | ﹤0.01% |
+56,600
| New | +$2.04M |
|
|
SMLR
2529
DELISTED
Semler Scientific
SMLR
| $2.19M | ﹤0.01% |
60,546
+52,995
| +702% | +$2.48M |
|
2530
PUT
Freshpet
FRPT
$3.48B
| $2.19M | ﹤0.01% |
26,300
-34,100
| -56% | -$4.17M |
|
2531
Capri Holdings
CPRI
$1.77B
| $2.19M | ﹤0.01% |
110,804
-151,132
| -58% | -$3.35M |
|
2532
CALL
Old Dominion Freight Line
ODFL
$44.1B
| $2.18M | ﹤0.01% |
13,200
| – | – |
|
2533
Ardelyx
ARDX
$1.01B
| $2.18M | ﹤0.01% |
443,240
-89,414
| -17% | -$480K |
|
2534
UiPath
PATH
$8.64B
| $2.18M | ﹤0.01% |
211,260
+41,611
| +25% | +$536K |
|
2535
Perdoceo Education
PRDO
$1.96B
| $2.16M | ﹤0.01% |
85,835
-28,743
| -25% | -$764K |
|
2536
Vera Therapeutics
VERA
$2.08B
| $2.15M | ﹤0.01% |
89,716
-9,432
| -10% | -$303K |
|
2537
UL Solutions
ULS
$15.5B
| $2.15M | ﹤0.01% |
38,192
+21,089
| +123% | +$1.12M |
|
2538
Orrstown Financial Services
ORRF
$850M
| $2.15M | ﹤0.01% |
71,708
-2,214
| -3% | -$74.2K |
|
2539
Accel Entertainment
ACEL
$1B
| $2.15M | ﹤0.01% |
216,812
-18,414
| -8% | -$200K |
|
2540
Global X Copper Miners ETF NEW
COPX
$7.97B
| $2.15M | ﹤0.01% |
54,907
-46,067
| -46% | -$1.84M |
|
2541
Ziff Davis
ZD
$1.92B
| $2.14M | ﹤0.01% |
57,045
-20,607
| -27% | -$988K |
|
2542
Origin Bancorp
OBK
$1.67B
| $2.14M | ﹤0.01% |
61,828
-17,230
| -22% | -$634K |
|
2543
Alpha Metallurgical Resources
AMR
$2.02B
| $2.14M | ﹤0.01% |
17,094
-3,068
| -15% | -$499K |
|
|
TRTX
2544
TPG RE Finance Trust
TRTX
$610M
| $2.14M | ﹤0.01% |
262,291
-79,430
| -23% | -$672K |
|
2545
Harmony Gold Mining
HMY
$12B
| $2.14M | ﹤0.01% |
144,722
-127,435
| -47% | -$1.42M |
|
2546
Ubiquiti
UI
$35B
| $2.14M | ﹤0.01% |
6,888
-3,605
| -34% | -$1.27M |
|
2547
CALL
Freeport-McMoran
FCX
$93.6B
| $2.13M | ﹤0.01% |
56,200
-1,271,300
| -96% | -$48.6M |
|
2548
Hillman Solutions
HLMN
$1.73B
| $2.12M | ﹤0.01% |
241,640
-98,093
| -29% | -$953K |
|
2549
Celldex Therapeutics
CLDX
$3.52B
| $2.12M | ﹤0.01% |
116,566
-26,348
| -18% | -$589K |
|
2550
PUT
GitLab
GTLB
$7.32B
| $2.12M | ﹤0.01% |
+45,000
| New | +$2.75M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.